Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveraging Everest's existing commercial organization - Exclusive Greater China license to develop and...
APX Lending Announces Landmark Decision of Canadian Securities Regulators
TORONTO, April 2, 2025 /PRNewswire/ -- APX Lending is pleased to announce the Canadian Securities Administrators (CSA) have issued a first-of-its kind decision, granting the company exemptive relief from certain registration and prospectus...